Fig 4 - by Maryam Banar (3220221)

Stability of Staphylococcus phage vB_SauR_SW21 and Staphylococcus phage vB_SauR_SW25 at various temperatures. by Maryam Banar (3220221)

Fig 8 - by Maryam Banar (3220221)

Comparison of the particular blood cell parameters across the various murine treatment groups. by Maryam Banar (3220221)

Stepped-Wedge Trial Diagram. by Sugy Choi (800862)

“…<div><p>Introduction</p><p>The United States is facing an opioid use disorder (OUD) epidemic, marked by unprecedented overdose death rates. In New York State, synthetic opioids significantly contribute to the increasing overdose deaths, disproportionately impacting Black and Latinx communities. …”

SPIRIT diagram for the QM2 Study. by Sugy Choi (800862)

“…<div><p>Introduction</p><p>The United States is facing an opioid use disorder (OUD) epidemic, marked by unprecedented overdose death rates. In New York State, synthetic opioids significantly contribute to the increasing overdose deaths, disproportionately impacting Black and Latinx communities. …”

Primers used for real-time qPCR. by Eloise Parry-Nweye (7548998)

“…These results provide new insights into indoor fomite-mediated viral transmission under different environmental conditions. …”

Western blotting identification of expression level of pyroptosis protein Gasdermin D (GSDMD) in IIL ESP-treated Caco-2 cells. by Qi Qi Lu (17721401)

S1 Graphical abstract - by Huimin Xian (20390006)

“…</p><p>Conclusions</p><p>In patients with MVD-STEMI, the incidence of MACEs was lower in FCR than in FIR, and the decrease was particularly significant in the DM cohort. …”

Procedural characteristics. by Huimin Xian (20390006)

“…</p><p>Conclusions</p><p>In patients with MVD-STEMI, the incidence of MACEs was lower in FCR than in FIR, and the decrease was particularly significant in the DM cohort. …”

Clinical characteristics. by Huimin Xian (20390006)

“…</p><p>Conclusions</p><p>In patients with MVD-STEMI, the incidence of MACEs was lower in FCR than in FIR, and the decrease was particularly significant in the DM cohort. …”

Study flowchart. by Huimin Xian (20390006)

“…</p><p>Conclusions</p><p>In patients with MVD-STEMI, the incidence of MACEs was lower in FCR than in FIR, and the decrease was particularly significant in the DM cohort. …”

Data. by Huimin Xian (20390006)

“…</p><p>Conclusions</p><p>In patients with MVD-STEMI, the incidence of MACEs was lower in FCR than in FIR, and the decrease was particularly significant in the DM cohort. …”

Pre- & post awareness session scores. by Stavia Turyahabwe (9925935)

“…TB treatment adherence rates among TB patients using VOT was significantly better (<i>p</i><0.01) than those using DOTS.…”

VOT vs DOTS TB treatment adherence rates. by Stavia Turyahabwe (9925935)

“…TB treatment adherence rates among TB patients using VOT was significantly better (<i>p</i><0.01) than those using DOTS.…”

Sample size and duration of the pilot study. by Stavia Turyahabwe (9925935)

“…TB treatment adherence rates among TB patients using VOT was significantly better (<i>p</i><0.01) than those using DOTS.…”

pHI for net status. by Job Oyweri (22041452)

“…Against the Kisumu susceptible <i><i>Anopheles gambiae</i></i> s.s, both net types decreased in mortality at baseline (when new) from 97.6% to 18.4% and 98.6% to 18.5% for pyrethroid and PBO-LLINs respectively at 18 months. …”

Combined net integrity PBO and LLINs-PLOS1. by Job Oyweri (22041452)

“…Against the Kisumu susceptible <i><i>Anopheles gambiae</i></i> s.s, both net types decreased in mortality at baseline (when new) from 97.6% to 18.4% and 98.6% to 18.5% for pyrethroid and PBO-LLINs respectively at 18 months. …”

Factors affecting pyrethroid-LLINs integrity. by Job Oyweri (22041452)

“…Against the Kisumu susceptible <i><i>Anopheles gambiae</i></i> s.s, both net types decreased in mortality at baseline (when new) from 97.6% to 18.4% and 98.6% to 18.5% for pyrethroid and PBO-LLINs respectively at 18 months. …”

Factors associated with mosquito net integrity. by Job Oyweri (22041452)

“…Against the Kisumu susceptible <i><i>Anopheles gambiae</i></i> s.s, both net types decreased in mortality at baseline (when new) from 97.6% to 18.4% and 98.6% to 18.5% for pyrethroid and PBO-LLINs respectively at 18 months. …”